Autologous T Cell Vaccine (TCV)

· Opexa Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Autologous T Cell Vaccine (TCV), covering 2014-03-10 to 2014-03-10. Get the full timeline:

Most recent: Clinical Trial Update: Autologous T Cell Vaccine (TCV) for Multiple Sclerosis [Phase 2]